Ramsay Health Care (RHC) Stock Overview
Owns and operates hospitals in Australia and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 1/6 |
| Dividends | 2/6 |
RHC Community Fair Values
Create NarrativeSee what 65 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Ramsay Health Care Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$44.16 |
| 52 Week High | AU$44.73 |
| 52 Week Low | AU$30.39 |
| Beta | 0.59 |
| 1 Month Change | 21.32% |
| 3 Month Change | 13.46% |
| 1 Year Change | 12.37% |
| 3 Year Change | -19.83% |
| 5 Year Change | -30.19% |
| Change since IPO | 1,916.44% |
Recent News & Updates
Narrative Update • Jun 23
RHC: UK Exit Speculation And Dividend Outlook Will Support Future Upside
Analysts have slightly lifted their price target for Ramsay Health Care to A$51.89 from A$51.81. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E expectations.
Narrative Update • Jun 04
RHC: Dividend Strength And Potential UK Exit Will Support Future Upside
Analysts have trimmed their price target for Ramsay Health Care slightly to A$42.65 from A$43.04, reflecting updated assumptions around discount rates, revenue growth, profit margins and forward P/E multiples. What's in the News Ramsay Health Care Limited announced an actual fully franked ordinary dividend of A$3.36080000 per share for the six months ending October 19, 2026, payable on October 20, 2026, with an ex date of September 29, 2026 and a record date of September 30, 2026 (Key Developments).
Narrative Update • May 14
RHC: Dividend Outlook And Possible UK Exit Will Shape Future Returns
Analysts have reduced their fair value estimate for Ramsay Health Care from A$35.60 to A$33.54, following updated assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News Ramsay Health Care declared a fully franked ordinary dividend of A$3.3608 per share for the six months ending October 19, 2026, payable on October 20, 2026, with an ex date of September 29, 2026 and a record date of September 30, 2026 (Key Developments).Narrative Update • Apr 29
RHC: Dividend Payouts And Possible UK Exit Will Shape Balanced Outlook
Analysts have nudged the price target for Ramsay Health Care slightly lower from A$35.70 to A$35.60, reflecting updated assumptions around the discount rate, revenue growth, profit margin and forward P/E multiples. What's in the News Ramsay Health Care declared an actual fully franked ordinary dividend of A$3.3608 per share for the six months ending October 19, 2026, payable on October 20, 2026, with an ex date of September 29, 2026 and record date of September 30, 2026 (Key Developments).Narrative Update • Apr 15
RHC: Margin Resilience And UK Exit Options Will Support Future Upside Potential
Analysts now place Ramsay Health Care's fair value at A$51.81, compared with A$48.05 previously. This reflects updated views on discount rates, revenue growth, profit margins and future P/E after recent Street research, including the latest Morgan Stanley downgrade review.Recent updates
Narrative Update • Jun 23
RHC: UK Exit Speculation And Dividend Outlook Will Support Future Upside
Analysts have slightly lifted their price target for Ramsay Health Care to A$51.89 from A$51.81. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E expectations.Narrative Update • Jun 04
RHC: Dividend Strength And Potential UK Exit Will Support Future Upside
Analysts have trimmed their price target for Ramsay Health Care slightly to A$42.65 from A$43.04, reflecting updated assumptions around discount rates, revenue growth, profit margins and forward P/E multiples. What's in the News Ramsay Health Care Limited announced an actual fully franked ordinary dividend of A$3.36080000 per share for the six months ending October 19, 2026, payable on October 20, 2026, with an ex date of September 29, 2026 and a record date of September 30, 2026 (Key Developments).Narrative Update • May 14
RHC: Dividend Outlook And Possible UK Exit Will Shape Future Returns
Analysts have reduced their fair value estimate for Ramsay Health Care from A$35.60 to A$33.54, following updated assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News Ramsay Health Care declared a fully franked ordinary dividend of A$3.3608 per share for the six months ending October 19, 2026, payable on October 20, 2026, with an ex date of September 29, 2026 and a record date of September 30, 2026 (Key Developments).Narrative Update • Apr 29
RHC: Dividend Payouts And Possible UK Exit Will Shape Balanced Outlook
Analysts have nudged the price target for Ramsay Health Care slightly lower from A$35.70 to A$35.60, reflecting updated assumptions around the discount rate, revenue growth, profit margin and forward P/E multiples. What's in the News Ramsay Health Care declared an actual fully franked ordinary dividend of A$3.3608 per share for the six months ending October 19, 2026, payable on October 20, 2026, with an ex date of September 29, 2026 and record date of September 30, 2026 (Key Developments).Narrative Update • Apr 15
RHC: Margin Resilience And UK Exit Options Will Support Future Upside Potential
Analysts now place Ramsay Health Care's fair value at A$51.81, compared with A$48.05 previously. This reflects updated views on discount rates, revenue growth, profit margins and future P/E after recent Street research, including the latest Morgan Stanley downgrade review.Narrative Update • Apr 01
RHC: Dividend Outlook And Tighter Assumptions Will Shape Future Share Performance
Analysts have trimmed their price target for Ramsay Health Care to about A$43.04 from about A$43.33, reflecting slightly lower revenue growth assumptions, a modestly higher discount rate, and a small adjustment to the future P/E multiple, partly offset by a slightly higher profit margin outlook. Analyst Commentary Bullish Takeaways Bullish analysts view the A$43.04 target as still supported by expectations for steady execution on revenue and profit margins, even after trimming growth assumptions.Narrative Update • Mar 18
RHC: Revised Assumptions And Dividend Outlook Will Shape Future Share Performance
Analysts have lifted their price target on Ramsay Health Care from around A$37.09 to about A$43.33, citing updated assumptions on discount rates, revenue growth, profit margins and future P/E multiples following recent research, including a downgrade from Morgan Stanley. Analyst Commentary Bullish Takeaways Bullish analysts view the lift in the consolidated price target to about A$43.33 as support for upside potential if Ramsay delivers on its revised revenue and margin assumptions.Narrative Update • Mar 04
RHC: Execution Risks Will Cap Upside Despite Higher Fair Value Estimate
Analysts now see fair value for Ramsay Health Care at A$35.70, up from A$33.97. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E multiples.Narrative Update • Feb 17
RHC: Higher Discount Rate And Lower P/E Will Shape Measured Outlook
Analysts have reduced their A$ price target for Ramsay Health Care to A$33.97. This reflects updated assumptions for the discount rate, revenue growth, profit margins and future P/E, which have also driven at least one recent downgrade in Street research.Narrative Update • Feb 03
RHC: CFO Appointment Will Support Risk Management While Outlook Remains Measured
Analysts have trimmed their price targets on Ramsay Health Care, reflecting a modest reset based on small tweaks to discount rate, revenue growth, profit margin and forward P/E assumptions following the latest sector views. Analyst Commentary Bearish analysts are treating the latest sector views as a reason to be more cautious on Ramsay Health Care, with price target resets framed around more conservative assumptions rather than any single headline event.Narrative Update • Jan 20
RHC: Future CFO Appointment Will Support Margins While Outlook Remains Measured And Balanced
Analysts have maintained their fair value estimate for Ramsay Health Care at A$33.97. The latest price target update reflects modest adjustments to assumptions around the discount rate, revenue growth, profit margins and future P/E, rather than a fundamental shift in their outlook.Narrative Update • Jan 06
RHC: Future CFO Appointment Will Steady Margins While Valuation Appears Balanced
Analysts have slightly reduced their price target for Ramsay Health Care from A$34.50 to A$33.97. The change reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E expectations.Analysis Article • Dec 26
We Think Ramsay Health Care (ASX:RHC) Is Taking Some Risk With Its Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Narrative Update • Dec 15
RHC: Future CFO Appointment Will Shape Margins And Earnings Profile
Narrative Update: Ramsay Health Care Analysts have modestly increased their price target for Ramsay Health Care to A$34.50 from A$32.80, citing slightly stronger expectations for revenue growth, profit margins and long term earnings multiples, despite a marginally higher discount rate. What's in the News Ramsay Health Care appointed Anthony Neilson as Group Chief Financial Officer, with commencement scheduled for 24 November 2025 in Sydney (Key Developments).Narrative Update • Dec 10
RHC: New Finance Leadership Will Support Stronger Margins And Future Returns
Analysts have nudged their price target for Ramsay Health Care slightly higher to A$48.05 from A$47.94. This reflects marginally stronger expectations for revenue growth and profit margins, despite a modest increase in the assumed discount rate and a slightly lower future P/E multiple.Analysis Article • Dec 09
Ramsay Health Care Limited's (ASX:RHC) Low P/S No Reason For Excitement
When close to half the companies operating in the Healthcare industry in Australia have price-to-sales ratios (or...Narrative Update • Nov 19
RHC: Marginal Profit Improvement Expected To Support Future Share Price Upside
Narrative Update on Ramsay Health Care Analysts have slightly reduced their price target for Ramsay Health Care from $37.23 to $37.09. This change reflects updated forecasts for revenue growth, profit margins, and discount rates.Narrative Update • Nov 04
RHC: Stable Profit Margins And Discount Rate Set To Support Share Strength
Analysts have maintained their fair value estimate for Ramsay Health Care at $37.23 per share. They cite stable growth and profitability projections, even though there has been a slight decrease in the discount rate used in their valuation models.Narrative Update • Oct 21
Analysts Lower Ramsay Health Care Target Price Amid Shifts in Valuation Metrics
The analyst price target for Ramsay Health Care has been revised downward from $38.11 to $37.23. This change reflects adjustments in analysts' expectations for key financial metrics, including slightly higher revenue growth and profit margin, offset by a higher discount rate and a reduced forward P/E ratio.Analysis Article • Sep 01
Ramsay Health Care (ASX:RHC) Has Announced A Dividend Of A$0.40
Ramsay Health Care Limited ( ASX:RHC ) will pay a dividend of A$0.40 on the 25th of September. Based on this payment...Narrative Update • Aug 29
Operational Rigor In Elysium And Tech Investments Will Improve Australian Hospital Efficiency
Ramsay Health Care’s fair value has been revised downward as weakening net profit margins and a higher future P/E ratio have raised concerns over earnings growth and valuation, reducing the consensus analyst price target from A$41.31 to A$38.56. Valuation Changes Summary of Valuation Changes for Ramsay Health Care The Consensus Analyst Price Target has fallen from A$41.31 to A$38.56.Analysis Article • Aug 22
Insufficient Growth At Ramsay Health Care Limited (ASX:RHC) Hampers Share Price
You may think that with a price-to-sales (or "P/S") ratio of 0.5x Ramsay Health Care Limited ( ASX:RHC ) is a stock...Analysis Article • Aug 01
Ramsay Health Care (ASX:RHC) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
New Narrative • Feb 09
Disciplined Investments And Digital Focus Will Drive Future Operating Efficiency
Disciplined transformation investments and engagement with payers could boost revenue, net margins, and earnings through enhanced productivity and better tariff indexation.Shareholder Returns
| RHC | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | 2.5% | -0.8% | -0.2% |
| 1Y | 12.4% | -10.0% | 1.0% |
Return vs Industry: RHC exceeded the Australian Healthcare industry which returned -10% over the past year.
Return vs Market: RHC exceeded the Australian Market which returned 1% over the past year.
Price Volatility
| RHC volatility | |
|---|---|
| RHC Average Weekly Movement | 3.6% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 9.6% |
| 10% most volatile stocks in AU Market | 17.0% |
| 10% least volatile stocks in AU Market | 4.0% |
Stable Share Price: RHC has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: RHC's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | 92,000 | Natalie Davis | www.ramsayhealth.com |
Ramsay Health Care Limited owns and operates hospitals in Australia and internationally. It offers health care services to public and private patients. The company was founded in 1964 and is based in St Leonards, Australia.
Ramsay Health Care Limited Fundamentals Summary
| RHC fundamental statistics | |
|---|---|
| Market cap | AU$10.03b |
| Earnings (TTM) | AU$273.00m |
| Revenue (TTM) | AU$18.62b |
37.2x
P/E Ratio0.5x
P/S RatioIs RHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RHC income statement (TTM) | |
|---|---|
| Revenue | AU$18.62b |
| Cost of Revenue | AU$16.41b |
| Gross Profit | AU$2.21b |
| Other Expenses | AU$1.94b |
| Earnings | AU$273.00m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Aug 27, 2026
| Earnings per share (EPS) | 1.19 |
| Gross Margin | 11.87% |
| Net Profit Margin | 1.47% |
| Debt/Equity Ratio | 98.3% |
How did RHC perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield69%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/03 13:50 |
| End of Day Share Price | 2026/07/03 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ramsay Health Care Limited is covered by 25 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Lyanne Harrison | BofA Global Research |
| Derek Jellinek | CGS International |